Jan 19, 2021 10:10am EST XORTX Provides Corporate Update; Synopsis of 2020 Achievements and Key Activities for 2021
Oct 08, 2020 10:14am EDT XORTX Receives Positive Feedback from FDA on COVID-19 Related Acute Kidney Injury
Sep 15, 2020 7:00am EDT XORTX Highlights New Studies of Acute Kidney Disease Due to COVID-19 Infection
Aug 31, 2020 7:00am EDT XORTX Files U.S. FDA Pre-IND Meeting Request for XRx-101 (Oxypurinol) COVID-19 Program and Pre-IND Meeting Submission